ENTITY

Insulet Corp (PODD US)

92
Analysis
Health Care • United States
Insulet Corporation is a medical device company that develops, manufactures and markets an insulin infusion system for people with insulin-dependent diabetes.
more
bullish•Eoflow
•21 Aug 2024 20:29

Eoflow: Rights Offering of 82 Billion Won and [Medtronic & Eoflow - Don't You Forget About Me]

After the market close on 21 August, Eoflow (294090 KS) announced a rights offering capital raise of 9.1 million new shares, representing share...

Logo
1k Views
Share
bullish•Exedy Corp
•23 Jun 2024 07:00

Last Week in Event SPACE: Exedy Corp, EOFlow, L'Occitane, Jardine Cycle & Carriage

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
620 Views
Share
bullish•Eoflow
•26 May 2024 07:00

Last Week in Event SPACE: Mitsui Matsushima, L'Occitane, Prosus/Tencent, EOFlow

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
727 Views
Share
bullish•Insulet Corp
•24 May 2024 15:00

Insulet Corporation: Will Its Innovative Edge In The Insulin Pump Market Last? - Major Drivers

Insulet Corporation reported an excellent first quarter of 2024 that has exceeded expectations. The demand for Omnipod 5 continues to rise, the...

Logo
425 Views
Share
bullish•Eoflow
•23 May 2024 12:08

EOFlow (294090 KS): Suitably Pumped

EOFlow is free to resume global sales. Medtronic is free to reengage. I'd be buying EOFlow. Then I'd buy some more. I'd be shorting Insulet.

Logo
897 Views
Share
x